Composition of the NRTI back-bone of the regimen started after the discontinuation of tenofovir (rows), according to the initial third drug (columns)–Selective tenofovir discontinuations.
Alessandro Cozzi-Lepri (195759) +11 more
core +1 more source
Background: The proposed basis for NRTI-associated fat wasting involves cellular mitochondrial DNA (mtDNA) depletion and mitochondrial dysfunction leading to clinical toxicities.
McKinnon, E. +5 more
core
Major protease inhibitor drug resistance mutations among patients with virological failure on second-line antiretroviral therapy in Zimbabwe: a retrospective cross-sectional study. [PDF]
Mayini J +7 more
europepmc +1 more source
A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval. [PDF]
Charpentier C +28 more
europepmc +1 more source
Application Value of In-House HIV-1 DNA Genotypic Resistance Testing for Individuals with Low-Level Viremia. [PDF]
Zhou Y +9 more
europepmc +1 more source
HIV-1 genotypic patterns in antiretroviral-naïve and treated patients in the integrase inhibitor era in Morocco. [PDF]
Ahmina M +16 more
europepmc +1 more source
Evaluation of Real-World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir/Lamivudine Fixed-Dose Combination in Treatment-Naive and Pretreated People Living With HIV Who are Virologically Suppressed, in Routine Clinical Care in France: Results From the CARAVEL Study. [PDF]
Philibert P +7 more
europepmc +1 more source
Understanding integrase inhibitor resistance in Angola: a comparative analysis of INSTI-naive and INSTI-experienced individuals. [PDF]
Pocongo B +19 more
europepmc +1 more source
A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab. [PDF]
Stefic K +28 more
europepmc +1 more source
Characterizing immune activation in HIV-exposed but uninfected infants in the first year of life. [PDF]
Roseto I +5 more
europepmc +1 more source

